27

10 2023

Esco Bioengineering Goes Global   Esco Bioengineering (formerly Cesco Bioengineering) Goes Global as Esco Lifesciences Group's Founding Family Takes the Helm Oct. 27

Company Name Change Notification  Dear Customers, Suppliers, and Partners,       We hope this message finds you well. We are excited to announce that CESCO BIOENG

10 2023

24

12

08 2019

Pandemic influenza vaccine production with TideCell  Dr. Hu in NHRI Taiwan describe how to produce pandemic influenza virus through TideCell HD cell culture system Publication Info

BelloCell Applies in Hepatitis C Virus Envelope Glycoprotein Production   Publication Info

01 2019

01

29

12 2018

TideCell for high titer rabies viral antigen production  YI-Kan Vaccine company in China describes how they produce high titer of rabies viral antigen through TideCell HD cell culture system. Publ

CESCO launches a PLC based TideCell-002  CESCO launches a PLC based TideCell-002 which adapts Siemens system to meet biopharmaceutical industries’ requirement on process reliability, an

12 2018

15

24

05 2018

Influenza vial antigen manufacture with TideCell system   Publication Info

BelloCell Appiles as an effective PK/PD study model especially for anti-cancer drugs   Publication Info

05 2018

01

31

10 2017

Drug interaction study with BelloCell system   Publication Info

Publication on how to increase viral vaccine antigens through BelloCell and TideCell systems  Dr. Xie in Chinese journal of Biotechnology introduces how to increase viral vaccine antigens through BelloCell and TideCell high density cell c

08 2017

25

1 2 ►